Search
for
Sort by
Research 841–870 of 1000+
- Skin Cell Heterogeneity in Development, Wound Healing, and Cancer
- Dermatoses of pregnancy
- An Integrated Transcriptome Atlas of Embryonic Hair Follicle Progenitors, Their Niche, and the Developing Skin
- Cutaneous complications of chemotherapeutic agents
- Skin CD4+ memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation
- Sic Transit Gloria: Farewell to the Epidermal Transit Amplifying Cell?
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Dermatological adverse events with taxane chemotherapy
- CD34 Expression by Hair Follicle Stem Cells Is Required for Skin Tumor Development in Mice
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Skin Pigmentation Types, Causes and Treatment—A Review
- Exosomes for repair, regeneration and rejuvenation
- Morpho-Regulation of Ectodermal Organs
- Probiotic Bacteria Induce a ‘Glow of Health’
- Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled
- The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
- Cell death in the skin
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Oral retinoids-present status
- Ultraviolet Radiation in Wound Care: Sterilization and Stimulation
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
- Cutaneous reactions to recombinant cytokine therapy
- The hair cycle
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Beyond acne: Current aspects of sebaceous gland biology and function
- Pharmacology of antiandrogens
- Control of hair follicle cell fate by underlying mesenchyme through a CSL–Wnt5a–FoxN1 regulatory axis
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction